Latest filing published 30 Oct 2017 for The Canadian Bioceutical Corporation.
No signal scores available.
This profile gathers the share dealings of Naser Bin Butti Almheiri in The Canadian Bioceutical Corporation. Between 19 January 2017 and 25 August 2017, the trades on record add up to 9 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 30 October 2017, reports a transaction in The Canadian Bioceutical Corporation. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations